Jun 27 |
Analysts Are Betting On Wave Life Sciences Ltd. (NASDAQ:WVE) With A Big Upgrade This Week
|
Jun 26 |
Update: WAVE Life Sciences Discloses 'Positive' Phase 1b/2a Data From Huntington's Disease Treatment But Shares Fall on Neurofilament Concern
|
Jun 25 |
What's Going On With Wave Life Sciences Stock On Tuesday?
|
Jun 25 |
Wave jumps on trial data for Huntington’s disease therapy
|
Jun 25 |
Wave, with new data, plots path forward for Huntington’s drug
|
Jun 25 |
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
|
Jun 12 |
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
|
May 30 |
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
|
May 15 |
Wells Fargo starts Wave Life Sciences at buy, cites valuation
|
May 12 |
Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
|